Overview of This Study:

The study involved four major activities to estimate the current market size for laboratory centrifuge market. Exhaustive secondary research was done to collect information on market, peer market, and parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Expected Revenue Growth:

The laboratory centrifuge market is expected to reach USD 1.2 billion by 2023 from USD 1.1 billion in 2018, at a CAGR of 2.8%. Market growth is primarily driven by factors such as technological advancements, increasing research, and a high prevalence of target diseases.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088

Market Dynamics:

Pharmaceutical and biotechnology companies, being an integral part of the life science industry, invest heavily in research to develop breakthrough molecules to meet the growing needs of the healthcare sector. Moreover, the impending patent cliff has also led to an increase in biopharmaceutical research activity.

According to the International Federation of Pharmaceutical Manufacturers & Associations, in 2015, global R&D investments by the pharmaceutical industry were estimated at USD 149.8 billion as compared to USD 141.6 billion in 2014. The combined R&D spending of PhRMA members in the biopharmaceutical sector increased to USD 58.8 billion in 2015 from USD 53.3 billion in 2014.

Companies operating in the life science instruments market also increased their R&D investments for the development of innovative products to meet the research requirements of pharmaceutical and biotechnology companies. For instance, Thermo Fisher Scientific increased its R&D investment from USD 692 million in 2015 to USD 888 million in 2017, while Eppendorf increased its R&D investment from USD 35.4 million in 2015 to USD 41.2 million in 2017. Since centrifuges are essential equipment in the research laboratories, the increase in R&D activities will boost the growth of the centrifuges market.

Technological advancements:

Innovation in the field of laboratory centrifuges is majorly centered on enhancing convenience, speed, compactness, safety, efficiency, and accuracy. Rotors used in centrifuges were earlier made of tensile steel, and then replaced with aluminum and titanium alloys. Carbon fiber rotors, in addition, are much lighter than their counterparts—these rotors weigh 8 kg, as opposed to earlier 21-kg aluminum rotors. Carbon fiber increases the flexibility of the rotor and makes them resistant to chemical corrosion and structural fatigue. The FIBERLite Fixed-Angle Rotor by Beckman Coulter (acquired by Danaher) and Thermo Scientific Fiberlite rotors, for example, are made of carbon fiber.

Asia to grow at the highest CAGR during the forecast period

The laboratory centrifuge market has been segmented into four major regions, namely, North America, Europe, Asia, and the Rest of the World (RoW). Currently, North America dominates the global laboratory centrifuges market, and this trend is expected to continue during the forecast period. However, the market in Asia is estimated to grow at the highest CAGR during the forecast period. The presence of emerging economies such as China and India and the increasing R&D investments by pharmaceutical and biotechnology companies in this region are the major factors supporting the growth of the Asian laboratory centrifuges market.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=197749088

Key Players:

Key players in the laboratory centrifuge market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), Sigma Laborzentrifugen GmbH (Germany), Andreas Hettich GmbH & Co. KG (Germany), Kubota Corporation (Japan), Koki Holdings Co., Ltd. (Japan) (previously Hitachi Koki Co., Ltd.), QIAGEN N.V. (Netherlands), NuAire (US), Sartorius (Germany), HERMLE Labortechnik GmbH (Germany), and Becton, Dickinson and Company (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]